Considerations for transition from subcutaneous to oral prophylaxis in the treatment of hereditary angioedema

Considerations for transition from subcutaneous to oral prophylaxis in the treatment of hereditary angioedema

Abstract Background Hereditary angioedema (HAE) is a rare genetic disorder characterized by unpredictable localized episodes of edema, which is frequently managed with long-term prophylactic medications. Until recently, long-term prophylaxis has predominantly required regular intravenous or subcutan...

Full description

Bibliographic Details
Main Authors: Richard G. Gower, Mary Wilber
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Hereditary angioedema
Treatment burden
Quality of life
Prophylactic treatment
Shared decision-making
Berotralstat
Online Access:https://doi.org/10.1186/s13223-021-00603-9

Internet

https://doi.org/10.1186/s13223-021-00603-9

Similar Items